封面
市場調查報告書
商品編碼
1747574

感染監測解決方案市場按產品/服務、感染疾病類型、最終用戶和地區分類

Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User and By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

感染監測解決方案市場規模預計在 2025 年達到 8.92 億美元,預計到 2032 年將達到 22.596 億美元,2025 年至 2032 年的複合年成長率為 14.2%。

分析範圍 分析詳細資訊
基準年 2024 市場規模(2025年) 8.92億美元
效能數據 2020-2024 預測期 2025-2032
預測期內的複合年成長率(2025-2032) 14.20% 預計金額(2032年) 22.596億美元

感染監測解決方案是一種軟體,可協助醫院和其他醫療機構向州和聯邦當局報告病患資料。感染監測解決方案用於醫療產業,收集醫院內感染數據並研究感染模式,以控制社區內感染的傳播。醫院內感染是感染疾病。該軟體會在感染疾病爆發時向醫院的網路通訊協定(IP) 發出警報,使醫院內感染 (HAI) 專家和護理人員能夠及時救治感染疾病患者,避免感染疾病爆發。感染監測解決方案是一種程序,可幫助醫療機構有效管理醫院內感染 (HAI)。肺炎、胃腸道疾病、尿道感染感染疾病以及某些手術相關的感染疾病是醫院內感染疾病(HAI) 的主要類型。醫院內感染疾病(HAI) 的高發生率是世界各國政府關注的重點問題,因此各國政府都制定了有效管理和減少醫院內感染 (HAI) 發生的政策。

市場動態

預計在預測期內,市場主要企業擴大採用非直接成長策略,例如透過收購來擴大產品系列,將推動市場成長。例如,2019年5月,軟體公司RLDatix宣布收購iContracts,後者是一家為多個行業提供雲端基礎的合約、合規和收益管理軟體的供應商。此次收購將RLDatix的病患安全平台與iContracts先進的策略管理功能結合,使組織首次能夠透過部署動態策略和程序來解決事件的根本原因。

本報告的主要特點

  • 本報告對全球感染監測解決方案市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模和複合年成長率。
  • 它還強調了每個細分市場的潛在商機,並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球感染監測解決方案市場的主要企業會根據以下參數進行分析,例如公司概況、產品系列、主要亮點、財務績效和策略。
  • 透過本報告的見解,負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
  • 「全球感染監測解決方案市場」報告涉及該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球感染監測解決方案市場的各種策略矩陣來簡化決策。

目錄

第1章 分析目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 主要亮點
  • 產品發布
  • 技術進步
  • PEST分析
  • 監管情景
  • 企業合併與收購(M&A)

第4章全球感染監測解決方案市場(按產品和服務分類)(2020-2032)

  • 軟體
  • 服務

5. 全球感染監測解決方案市場(按感染疾病類型分類)(2020-2032 年)

  • 手術部位感染疾病
  • 血流感染疾病
  • 尿道感染

6. 全球感染監測解決方案市場(按最終用戶分類)(2020-2032 年)

  • 醫院
  • 診所
  • 門診手術中心
  • 其他(專門中心等)

7. 全球感染監測解決方案市場(按地區) (2020-2032)

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韓國
      • 其他亞太地區
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第8章 競爭態勢

  • Baxter
  • BD
  • STERIS
  • Getinge AB
  • Medtronic
  • Koninklijke Philips NV
  • Abbott
  • Medexter Healthcare
  • Asolva
  • GOJO Industries, Inc.
  • Wolters Kluwer NV
  • VigiLanz Corporation
  • RLDatix
  • Roper Technologies, Inc.
  • Health Outcomes Worldwide
  • OpGen, Inc.
  • Urovant Sciences
  • Premier

第9章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI1699

Infection Surveillance Solutions Market is estimated to be valued at USD 892 Mn in 2025 and is expected to reach USD 2,259.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 14.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 892 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.20% 2032 Value Projection: USD 2,259.6 Mn

Infection surveillance solution is software that helps healthcare facilities such as hospitals and others to report data related to patients, to the state and federal authorities. Infection surveillance solutions are used in the healthcare industry to collect data on nosocomial infections to study the pattern of infections and regulate their spread in the community. Nosocomial infections are infections that are spread to people from hospitals or healthcare centers. This software alerts hospital Internet Protocol (IPs) in case of infection occurrence so that HAI specialists and nurses can treat patients suffering from the infection in order to avoid outbreaks of infection. Infection surveillance solutions are programs, which help in the effective management of the Healthcare-Acquired Infections (HAIs) in healthcare facilities. Pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and infections related to some surgery are the few major Healthcare-Acquired Infections (HAIs). High incidences of Healthcare-Acquired Infections (HAIs) is a major concern for government across the globe, and hence, various governments have outlined policies to effectively manage and reduce incidences of HAIs.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2019, RLDatix, a software company, announced that they had acquired iContracts, a provider of cloud-based contract, compliance, and revenue management software for multiple industries. The acquisition brings together the RLDatix patient safety platform with iContracts leading policy management capabilities to allow organizations, for the first time, to take action on the root causes of incidents through the implementation of policies and procedures that are dynamic.

Key features of the study

  • This report provides in-depth analysis of the global infection surveillance solutions market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global infection surveillance solutions market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences, and Premier
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global infection surveillance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infection surveillance solutions market

Market Segmentation

  • Global Infection Surveillance Solutions Market, By Products and Services
    • Software
    • On-Premises
    • Web-Based
    • Services
    • Support & Maintenance
    • Training & Consulting
  • Global Infection Surveillance Solutions Market, By Infection Type
    • Surgical Site Infections
    • Blood Stream Infections
    • Urinary Tract Infections
  • Global Infection Surveillance Solutions Market, By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Other (Specialty Center, etc.)
  • Global Infection Surveillance Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Baxter
    • BD
    • STERIS
    • Getinge AB
    • Medtronic
    • Koninklijke Philips N.V.
    • Abbott
    • Medexter Healthcare
    • Asolva
    • GOJO Industries, Inc.
    • Wolters Kluwer N.V.
    • VigiLanz Corporation
    • RLDatix
    • Roper Technologies, Inc.
    • Health Outcomes Worldwide
    • OpGen, Inc.
    • Urovant Sciences
    • Premier

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Products and Services
    • Market Snapshot, By Infection Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product Launch
  • Technological Advancements
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Infection Surveillance Solutions Market, By 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
      • On-Premises
      • Web-Based
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
      • Support & Maintenance
      • Training & Consulting

5. Global Infection Surveillance Solutions Market, By Infection Type, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Site Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Blood Stream Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Urinary Tract Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Infection Surveillance Solutions Market, By End User, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Ambulatory Surgical Center
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Others (Specialty Center, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Infection Surveillance Solutions Market, By Region, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STERIS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Getinge AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medexter Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Asolva
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GOJO Industries, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Wolters Kluwer N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • VigiLanz Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • RLDatix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Roper Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Health Outcomes Worldwide
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OpGen, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Urovant Sciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Premier
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us